0001705381-21-000002.txt : 20210510 0001705381-21-000002.hdr.sgml : 20210510 20210510103809 ACCESSION NUMBER: 0001705381-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210510 DATE AS OF CHANGE: 20210510 EFFECTIVENESS DATE: 20210510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CeleCor Therapeutics, Inc. CENTRAL INDEX KEY: 0001705381 IRS NUMBER: 870723255 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-398701 FILM NUMBER: 21905620 BUSINESS ADDRESS: STREET 1: 1155 CAMINO DEL MAR STREET 2: SUITE 481 CITY: DEL MAR STATE: CA ZIP: 92014 BUSINESS PHONE: 858-777-9750 MAIL ADDRESS: STREET 1: 1155 CAMINO DEL MAR STREET 2: SUITE 481 CITY: DEL MAR STATE: CA ZIP: 92014 D 1 primary_doc.xml X0708 D LIVE 0001705381 CeleCor Therapeutics, Inc. 1155 CAMINO DEL MAR SUITE 481 DEL MAR CA CALIFORNIA 92014 858-777-9750 DELAWARE None None Corporation true 2017 Robert Hillman 4963 Hidden Dune Court San Diego CA CALIFORNIA 92130 Executive Officer Director President, Treasurer and Director Peter B. Finn 53 State Street Boston MA MASSACHUSETTS 02109 Executive Officer Secretary Andreas Ritzi 1155 Camino Del Mar Suite 481 Del Mar CA CALIFORNIA 92014 Director Jack Lief 1155 Camino Del Mar Suite 481 Del Mar CA CALIFORNIA 92014 Director Biotechnology Decline to Disclose 06b false 2021-05-03 false true false 250000 5000000 1000000 4000000 false 1 0 0 0 true false CeleCor Therapeutics, Inc. Peter B. Finn Peter B. Finn Secretary 2021-05-10